Mariner
HCAT icon

Mariner’s Health Catalyst HCAT Stock Holding History

Mariner’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-12,476
Closed -$93.9K – 3221
2024
Q1 		$93.9K Sell
12,476
-194
-2% -$1.77K ﹤0.01% 2942
2023
Q4 		$117K Sell
12,670
-7,626
-38% -$62.3K ﹤0.01% 2824
2023
Q3 		$205K Sell
20,296
-1,132
-5% -$13.5K ﹤0.01% 2485
2023
Q2 		$268K Sell
21,428
-4,551
-18% -$54.2K ﹤0.01% 2220
2023
Q1 		$303K Sell
25,979
-734
-3% -$9.36K ﹤0.01% 2060
2022
Q4 		$284K Buy
26,713
+13,603
+104% +$131K ﹤0.01% 2073
2022
Q3 		$127K Buy
+13,110
New +$174K ﹤0.01% 2153

Other funds holding HCAT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
DG
Daventry Group New York $133M AUM 32.28% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Mariner's HCAT Position: Q2 2024 in Review

Mariner sold out of Health Catalyst (HCAT) in Q2 2024, closing a stake of 12,476 shares — an estimated $93.9K sold.

Mariner first reported a position in HCAT in Q3 2022 and held it in 7 quarters. The position peaked at $303K in Q1 2023. 161 funds tracked by Wall St. Rank hold HCAT as of Q2 2024.

  • Mariner reported no remaining Health Catalyst position as of Q2 2024 after selling out during the quarter.
  • Mariner sold 12,476 Health Catalyst shares in Q2 2024, an estimated $93.9K.
  • Mariner first reported a position in Health Catalyst in Q3 2022 and held it in 7 quarters.
  • Mariner's Health Catalyst position peaked at $303K in Q1 2023.
  • 161 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2024.

Based on Mariner's 13F filing for Q2 2024, filed 13 Aug 2024.